BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmed S, Zimba O, Gasparyan AY. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020;39:2529-2543. [PMID: 32654082 DOI: 10.1007/s10067-020-05275-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Urwyler P, Moser S, Trendelenburg M, Sendi P, Osthoff M. Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. Mol Immunol 2022;150:99-113. [PMID: 36030710 DOI: 10.1016/j.molimm.2022.08.008] [Reference Citation Analysis]
2 Angelika W, Erika GS, Michael K, Hannes S, Ingrid P, Sabine EH, Peter Q, Oswald W, Ursula W, Katharina GP. Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers. Thromb Res 2022;218:142-4. [PMID: 36037550 DOI: 10.1016/j.thromres.2022.08.005] [Reference Citation Analysis]
3 Goßlau Y, Warm TD, Hernandez Cancino EF, Kirchberger I, Meisinger C, Linseisen J, Hyhlik-Duerr A. The prevalence of vascular complications in SARS-CoV-2 infected outpatients. Wien Med Wochenschr 2022. [PMID: 35939218 DOI: 10.1007/s10354-022-00954-x] [Reference Citation Analysis]
4 Falcinelli E, Petito E, Gresele P. The role of platelets, neutrophils and endothelium in COVID-19 infection. Expert Rev Hematol 2022. [PMID: 35930267 DOI: 10.1080/17474086.2022.2110061] [Reference Citation Analysis]
5 Ho JW, Chao CL, Helenowski IB, Dwyer A, Vavra AK, Eskandari MK, Hekman KE, Tomita TM. Efficacy and safety of sonographer discretion to terminate a venous duplex ultrasound for diagnosis of deep venous thrombosis in COVID-19 patients. J Vasc Surg Venous Lymphat Disord 2022:S2213-333X(22)00322-5. [PMID: 35931361 DOI: 10.1016/j.jvsv.2022.06.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Musick JO, Fibben KS, Lam WA. Hyperviscosity syndromes; hemorheology for physicians and the use of microfluidic devices. Curr Opin Hematol 2022. [PMID: 35916537 DOI: 10.1097/MOH.0000000000000735] [Reference Citation Analysis]
7 Mohamed AS, Ahmad HM, Abdul-Raheem ASA, Kamel FMM, Khames A, Mady AF. Thromboprophylaxis and clinical outcomes in moderate COVID-19 patients: A comparative study. Res Social Adm Pharm 2022:S1551-7411(22)00208-X. [PMID: 35864037 DOI: 10.1016/j.sapharm.2022.07.004] [Reference Citation Analysis]
8 Orea-tejada A, Sánchez-moreno C, Aztatzi-aguilar OG, Sierra-vargas MP, González-islas D, Debray-garcía Y, Ortega-romero MS, Keirns-davis C, Cornejo-cornejo L, Aguilar-meza J. Plasma Endothelial and Oxidative Stress Biomarkers Associated with Late Mortality in Hospitalized COVID-19 Patients. JCM 2022;11:3950. [DOI: 10.3390/jcm11143950] [Reference Citation Analysis]
9 Soma P, Bester J. Pathophysiological Changes in Erythrocytes Contributing to Complications of Inflammation and Coagulation in COVID-19. Front Physiol 2022;13:899629. [DOI: 10.3389/fphys.2022.899629] [Reference Citation Analysis]
10 de Vries MP, Mohammadnia N, Simsek S, Schoorl M. Eosinopenia and increased markers of endothelial damage are characteristic of COVID-19 infection at time of hospital admission. Scand J Clin Lab Invest 2022;:1-6. [PMID: 35621384 DOI: 10.1080/00365513.2022.2079095] [Reference Citation Analysis]
11 Kondashevskaya MV. Horizons of Heparin Therapy in COVID-19 and Pandemic-Related Diseases. J Evol Biochem Phys 2022;58:523-34. [DOI: 10.1134/s002209302202020x] [Reference Citation Analysis]
12 Mohini, Priyadarshini S, Rath SK, Verma C, Das A. Poorer Obstetrics Outcomes During the Second Wave of COVID-19 in India. J Obstet Gynaecol India 2022;:1-7. [PMID: 35528222 DOI: 10.1007/s13224-022-01641-y] [Reference Citation Analysis]
13 Evangelatos G, Bamias G, Kitas GD, Kollias G, Sfikakis PP. The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era. Rheumatol Int 2022. [PMID: 35503130 DOI: 10.1007/s00296-022-05136-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shaik A, Chen Q, Mar P, Kim H, Mejia P, Pacheco H, Goonewardena SN, Cho DJ, Rosenson RS. Blood hyperviscosity in acute and recent COVID-19 infection. CH 2022. [DOI: 10.3233/ch-221429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, Entezari S, Ansari A, Poudineh M, Deravi N. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci 2022;9:804109. [DOI: 10.3389/fmolb.2022.804109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sastry S, Cuomo F, Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thrombosis Research 2022;212:51-7. [DOI: 10.1016/j.thromres.2022.02.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 Srivastava S, Garg I, Dogra V, Bargotya M, Bhattar S, Gupta U, Jain S, Hussain J, Hembrom AA, Ghosh N, Kumar V, Varshney R, Ganju L. Implications of COVID-19 on Thrombotic Profile of Severely Affected Patients. Pathobiology 2022;:1-11. [PMID: 35344951 DOI: 10.1159/000522543] [Reference Citation Analysis]
19 Olas B. The Antioxidant, Anti-Platelet and Anti-Coagulant Properties of Phenolic Compounds, Associated with Modulation of Hemostasis and Cardiovascular Disease, and Their Possible Effect on COVID-19. Nutrients 2022;14:1390. [DOI: 10.3390/nu14071390] [Reference Citation Analysis]
20 Armentano GM, Carneiro-Ramos MS. Effect of COVID-19 on cardiorenal axis: known or unknown universe? Braz J Med Biol Res 2022;55:e11932. [PMID: 35319675 DOI: 10.1590/1414-431X2022e11932] [Reference Citation Analysis]
21 Lawal IO, Kgatle MM, Mokoala K, Farate A, Sathekge MM. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2. BMC Cardiovasc Disord 2022;22:93. [PMID: 35264107 DOI: 10.1186/s12872-022-02534-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Minjauw C, Wautier D, Mundama M. Mono-articular idiopathic heterotopic ossification in a Coronavirus infected patient admitted in the intensive care unit. Acta Orthop Belg 2022;88:206-10. [PMID: 35512173 DOI: 10.52628/88.1.26] [Reference Citation Analysis]
23 Vedula P, Tang H, Speicher DW, Kashina A; The UPenn COVID Processing Unit. Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma. Front Cell Dev Biol 2022;10:807149. [DOI: 10.3389/fcell.2022.807149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mukherjee AK, Chattopadhyay DJ. Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19. Phytother Res 2022. [PMID: 35147268 DOI: 10.1002/ptr.7408] [Reference Citation Analysis]
25 García-callejo FJ, Balaguer-garcía R, Lis-sancerni MD, Ruescas L, Murcia-lópez M. Blood viscosity in COVID-19 patients with sudden deafness. Acta Otorrinolaringologica (English Edition) 2022. [DOI: 10.1016/j.otoeng.2022.02.004] [Reference Citation Analysis]
26 Nemetski SM, Ip A, Josephs J, Hellmann M. Clotting events among hospitalized patients infected with COVID-19 in a large multisite cohort in the United States. PLoS One 2022;17:e0262352. [PMID: 34986205 DOI: 10.1371/journal.pone.0262352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tholin B, Fiskvik H, Tveita A, Tsykonova G, Opperud H, Busterud K, Mpinganzima C, Garabet L, Ahmed J, Stavem K, Ghanima W. Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis. Thrombosis Update 2022. [DOI: 10.1016/j.tru.2021.100096] [Reference Citation Analysis]
28 Negoro H, Chatziantonio C, Razzaque MS. Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis. Expert Review of Anti-infective Therapy. [DOI: 10.1080/14787210.2022.2020097] [Reference Citation Analysis]
29 Willems LH, Nagy M, Ten Cate H, Spronk HMH, Groh LA, Leentjens J, Janssen NAF, Netea MG, Thijssen DHJ, Hannink G, van Petersen AS, Warlé MC. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res 2022;209:106-14. [PMID: 34922160 DOI: 10.1016/j.thromres.2021.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Zöllkau J, Hagenbeck C, Hecher K, Pecks U, Schlembach D, Simon A, Schlösser R, Schleußner E. [Recommendations for SARS-CoV-2/COVID-19 during Pregnancy, Birth and Childbed - Update November 2021 (Long Version)]. Z Geburtshilfe Neonatol 2021. [PMID: 34918334 DOI: 10.1055/a-1688-9398] [Reference Citation Analysis]
31 Gonzalez-Gonzalez FJ, Ziccardi MR, McCauley MD. Virchow's Triad and the Role of Thrombosis in COVID-Related Stroke. Front Physiol 2021;12:769254. [PMID: 34858214 DOI: 10.3389/fphys.2021.769254] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Raiker R, Pakhchanian H, Kavadichanda C, Gupta L, Kardeş S, Ahmed S. Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network. Clin Rheumatol 2021. [PMID: 34837569 DOI: 10.1007/s10067-021-05979-y] [Reference Citation Analysis]
34 D'Agnillo F, Walters KA, Xiao Y, Sheng ZM, Scherler K, Park J, Gygli S, Rosas LA, Sadtler K, Kalish H, Blatti CA 3rd, Zhu R, Gatzke L, Bushell C, Memoli MJ, O'Day SJ, Fischer TD, Hammond TC, Lee RC, Cash JC, Powers ME, O'Keefe GE, Butnor KJ, Rapkiewicz AV, Travis WD, Layne SP, Kash JC, Taubenberger JK. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med 2021;13:eabj7790. [PMID: 34648357 DOI: 10.1126/scitranslmed.abj7790] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
35 Barac S, Onofrei RR, Neagoe PV, Popescu AI, Pantea S, Rață AL. An Observational Study on Patients with Acute Limb Ischemia and SARS-CoV-2 Infection: Early and Late Results in Limb Salvage Rate. J Clin Med 2021;10:5083. [PMID: 34768611 DOI: 10.3390/jcm10215083] [Reference Citation Analysis]
36 Goßlau Y, Warm TD, Hernandez Cancino EF, Braun G, Spring O, Zerwes S, Hyhlik-Dürr A. [Deep Vein Thrombosis in Intensive Care Patients with COVID-19 Infection - Impact of a Standardised Therapeutic Regimen]. Zentralbl Chir 2021;146:605-11. [PMID: 34706375 DOI: 10.1055/a-1630-8163] [Reference Citation Analysis]
37 Khuda Bakhsh Z, Khan R, Al-Khafaji F, Achyuth Suresh V, Bashir K. Thrombosis of Bilateral Profunda Femoris, Anterior Tibial, and Tibioperoneal Arteries in a Patient With COVID-19 Infection. Cureus 2021;13:e17623. [PMID: 34646673 DOI: 10.7759/cureus.17623] [Reference Citation Analysis]
38 Raiker R, Pakhchanian H, DeYoung C, Gupta L, Kardeş S, Ahmed S, Kavadichanda C. Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network. J Autoimmun 2021;:102730. [PMID: 34649723 DOI: 10.1016/j.jaut.2021.102730] [Reference Citation Analysis]
39 Karabulut K, Kapici A, Andronikashvili A, Morgan J. A review of aortic thrombosis in COVID-19 infection. Exploration of Medicine. [DOI: 10.37349/emed.2021.00059] [Reference Citation Analysis]
40 Koçyiğit BF, Akyol A. PHYSICAL MEDICINE AND REHABILITATION APPROACHES IN THROMBOSIS ASSOCIATED WITH COVID-19. CAJMHE 2021;2:137-45. [DOI: 10.47316/cajmhe.2021.2.3.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kirkham AM, Monaghan M, Bailey AJM, Shorr R, Lalu MM, Fergusson DA, Allan DS. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol. Syst Rev 2021;10:249. [PMID: 34526123 DOI: 10.1186/s13643-021-01803-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Abacioglu OO, Yildirim A. The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19. Rev Assoc Med Bras (1992) 2021;67:443-8. [PMID: 34468612 DOI: 10.1590/1806-9282.20200983] [Reference Citation Analysis]
43 Raiker R, DeYoung C, Pakhchanian H, Ahmed S, Kavadichanda C, Gupta L, Kardeş S. Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States. Semin Arthritis Rheum 2021;51:1057-66. [PMID: 34450504 DOI: 10.1016/j.semarthrit.2021.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Devreese KMJ. COVID-19-related laboratory coagulation findings. Int J Lab Hematol 2021;43 Suppl 1:36-42. [PMID: 34288440 DOI: 10.1111/ijlh.13547] [Reference Citation Analysis]
45 Stute NL, Stickford ASL, Stickford JL, Province VM, Augenreich MA, Bunsawat K, Alpenglow JK, Wray DW, Ratchford SM. Altered central and peripheral haemodynamics during rhythmic handgrip exercise in young adults with SARS-CoV-2. Exp Physiol 2021. [PMID: 34311498 DOI: 10.1113/EP089820] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
46 Nassar M, Nso N, Alfishawy M, Novikov A, Yaghi S, Medina L, Toz B, Lakhdar S, Idrees Z, Kim Y, Gurung DO, Siddiqui RS, Zheng D, Agladze M, Sumbly V, Sandhu J, Castillo FC, Chowdhury N, Kondaveeti R, Bhuiyan S, Perez LG, Ranat R, Gonzalez C, Bhangoo H, Williams J, Osman AE, Kong J, Ariyaratnam J, Mohamed M, Omran I, Lopez M, Nyabera A, Landry I, Iqbal S, Gondal AZ, Hassan S, Daoud A, Baraka B, Trandafirescu T, Rizzo V. Current systematic reviews and meta-analyses of COVID-19. World J Virol 2021; 10(4): 182-208 [PMID: 34367933 DOI: 10.5501/wjv.v10.i4.182] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
47 García-Callejo FJ. [Blood viscosity in Covid-19 patients with sudden deafness]. Acta Otorrinolaringol Esp (Engl Ed) 2021. [PMID: 34305143 DOI: 10.1016/j.otorri.2021.07.001] [Reference Citation Analysis]
48 Bandapaati S, Bobba H, Navinan MR. Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence? BMJ Case Rep 2021;14:e243799. [PMID: 34261633 DOI: 10.1136/bcr-2021-243799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Patnaik S, Jain MK, Ahmed S, Dash AK, P RK, Sahoo B, Mishra R, Behera MR. Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Rheumatol Int 2021. [PMID: 34259880 DOI: 10.1007/s00296-021-04932-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci 2021;78:5953-76. [PMID: 34223911 DOI: 10.1007/s00018-021-03889-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Görgün S, Cindoruk Ş, Özgen E, Yadigaroğlu M, Demir MT, Yücel M, Akpınar ÇK, Güzel M. Diagnostic and Prognostic Value of Serum Endocan Levels in Patients With COVID-19. Angiology 2021;:33197211026044. [PMID: 34180269 DOI: 10.1177/00033197211026044] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Cuthbert R, Ferguson D, Kayani B, Haque S, Ali A, Parkar A, Bates P, Vemulapalli K. Evidence-based approach to providing informed consent for hip fracture surgery during the COVID-19 era. World J Orthop 2021; 12(6): 386-394 [PMID: 34189076 DOI: 10.5312/wjo.v12.i6.386] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Misra DP, Thomas KN, Gasparyan AY, Zimba O. Mechanisms of thrombosis in ANCA-associated vasculitis. Clin Rheumatol 2021. [PMID: 34109491 DOI: 10.1007/s10067-021-05790-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Alfarouk KO, AlHoufie STS, Ahmed SBM, Shabana M, Ahmed A, Alqahtani SS, Alqahtani AS, Alqahtani AM, Ramadan AM, Ahmed ME, Ali HS, Bashir A, Devesa J, Cardone RA, Ibrahim ME, Schwartz L, Reshkin SJ. Pathogenesis and Management of COVID-19. J Xenobiot 2021;11:77-93. [PMID: 34063739 DOI: 10.3390/jox11020006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
55 Weeks LD, Sylvester KW, Connors JM, Connell NT. Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study. Res Pract Thromb Haemost 2021;5:e12521. [PMID: 34013153 DOI: 10.1002/rth2.12521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
57 Arifputra J, Haroen H, Rotty LWA, Lasut PFC, Hendratta C. Coagulopathy of Coronavirus Disease 2019: A Case Series. Open Access Maced J Med Sci 2020;9:301-7. [DOI: 10.3889/oamjms.2021.6026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
58 Singh B, Kaur P, Patel P, Nabati C, Ayad S, Shamoon F, Maroules M. COVID-19 and arterial thrombosis: Report of 2 cases. Radiol Case Rep 2021;16:1603-7. [PMID: 33968287 DOI: 10.1016/j.radcr.2021.04.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
60 Daisley H Jr, Rampersad A, Daisley M, Ramdin A, Acco O, Narinesingh F, Humphrey O. COVID-19: a closer look at the pathology in two autopsied cases. Is the pericyte at the center of the pathological process in COVID-19? Autops Case Rep 2021;11:e2021262. [PMID: 34307223 DOI: 10.4322/acr.2021.262] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Najim M, Rahhal A, Khir F, Aljundi AH, Abu Yousef S, Ibrahim F, Amer A, Mohamed AS, Saleh S, Alfaridi D, Mahfouz A, Alyafei S, Howady F, Khatib M, Alemadi SA. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study. Rheumatol Int 2021;41:1243-52. [PMID: 33954813 DOI: 10.1007/s00296-021-04875-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
62 Ferrer-Oliveras R, Mendoza M, Capote S, Pratcorona L, Esteve-Valverde E, Cabero-Roura L, Alijotas-Reig J. Immunological and physiopathological approach of COVID-19 in pregnancy. Arch Gynecol Obstet 2021;304:39-57. [PMID: 33945026 DOI: 10.1007/s00404-021-06061-3] [Reference Citation Analysis]
63 Hamidi SH, Kadamboor Veethil S, Hamidi SH. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective. Pharmacol Rep 2021;73:712-27. [PMID: 33880743 DOI: 10.1007/s43440-021-00255-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Tiwari NR, Phatak S, Sharma VR, Agarwal SK. COVID-19 and thrombotic microangiopathies. Thromb Res 2021;202:191-8. [PMID: 33894421 DOI: 10.1016/j.thromres.2021.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
65 Prasun P. COVID-19: A Mitochondrial Perspective. DNA Cell Biol 2021;40:713-9. [PMID: 33872068 DOI: 10.1089/dna.2020.6453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
66 Gencler OS, Ege MR, Aslan A. Unilateral common carotid artery dissection in a patient with recent COVID-19: An association or a coincidence? J Clin Neurosci 2021;87:26-8. [PMID: 33863528 DOI: 10.1016/j.jocn.2021.02.010] [Reference Citation Analysis]
67 Chandra A, Chakraborty U, Ghosh S, Dasgupta S. Anticoagulation in COVID-19: current concepts and controversies. Postgrad Med J 2021:postgradmedj-2021-139923. [PMID: 33850011 DOI: 10.1136/postgradmedj-2021-139923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
68 Speciale A, Muscarà C, Molonia MS, Cimino F, Saija A, Giofrè SV. Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects. Phytother Res 2021;35:4616-25. [PMID: 33822421 DOI: 10.1002/ptr.7107] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
69 de Leeuw AJM, Oude Luttikhuis MAM, Wellen AC, Müller C, Calkhoven CF. Obesity and its impact on COVID-19. J Mol Med (Berl) 2021;99:899-915. [PMID: 33824998 DOI: 10.1007/s00109-021-02072-4] [Reference Citation Analysis]
70 Sashindranath M, Nandurkar HH. Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19. Stroke 2021;52:1895-904. [PMID: 33794655 DOI: 10.1161/STROKEAHA.120.032711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
71 Carbillon L, Fermaut M, Benbara A, Boujenah J. COVID-19, Virchow's triad and thromboembolic risk in obese pregnant women. Clin Cardiol 2021;44:593-4. [PMID: 33760245 DOI: 10.1002/clc.23602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Alabyad D, Rangaraju S, Liu M, Imran R, Kempton CL, Sharifpour M, Auld SC, Gaddh M, Sniecinski R, Maier CL, Guarner J, Duncan A, Nahab F. Validation of an admission coagulation panel for risk stratification of COVID-19 patients. PLoS One 2021;16:e0248230. [PMID: 33740793 DOI: 10.1371/journal.pone.0248230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Ulanowska M, Olas B. Modulation of Hemostasis in COVID-19; Blood Platelets May Be Important Pieces in the COVID-19 Puzzle. Pathogens 2021;10:370. [PMID: 33808640 DOI: 10.3390/pathogens10030370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 2021;40:2611-9. [PMID: 33733315 DOI: 10.1007/s10067-021-05691-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
75 Nasir U, Ahmad S. Management and Perspective of Coronavirus Disease 2019 (COVID-19), Pregnancy, and Hypercoagulability. SN Compr Clin Med 2021;:1-4. [PMID: 33723526 DOI: 10.1007/s42399-021-00854-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Lu W, Kelley W, Fang DC, Joshi S, Kim Y, Paroder M, Tanhehco Y, Tran MH, Pham HP. The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence. J Clin Apher 2021;36:483-91. [PMID: 33578448 DOI: 10.1002/jca.21883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Wijeratne T, Gillard Crewther S, Sales C, Karimi L. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review. Front Neurol 2020;11:607221. [PMID: 33584506 DOI: 10.3389/fneur.2020.607221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
78 Wang SC, Wang YF. Cardiovascular protective properties of oxytocin against COVID-19. Life Sci 2021;270:119130. [PMID: 33513400 DOI: 10.1016/j.lfs.2021.119130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, Sicari F, Vernelli C, Di Giuli C, Andreani P, Mariottini A, Francucci M, Sensi E, Costantini M, Bruzzone P, D'Andrea V, Gioia S, Cirocchi R, Tiri B. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It. J Clin Med 2021;10:297. [PMID: 33467466 DOI: 10.3390/jcm10020297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
80 Raza HA, Tariq J, Agarwal V, Gupta L. COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. Rheumatol Int 2021;41:257-73. [PMID: 33386447 DOI: 10.1007/s00296-020-04759-2] [Reference Citation Analysis]
81 Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gómez-Arbeláez D, Ibarra G, Garcia-Gutierrez A. Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 2021;156:112-7. [PMID: 33521296 DOI: 10.1016/j.medcle.2020.10.008] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
82 Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci 2020;10:148. [PMID: 33380340 DOI: 10.1186/s13578-020-00519-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
83 Sadeghmousavi S, Rezaei N. COVID-19 infection and stroke risk. Rev Neurosci 2021;32:341-9. [PMID: 33580645 DOI: 10.1515/revneuro-2020-0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Cagnacci A, Fruzzetti F. The use of combined hormonal contraceptives amid the COVID-19 pandemic. Reply. Eur J Contracept Reprod Health Care 2021;26:87-8. [PMID: 33245017 DOI: 10.1080/13625187.2020.1850678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Alonso MN, Mata-Forte T, García-León N, Vullo PA, Ramirez-Olivencia G, Estébanez M, Álvarez-Marcos F. Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients. Vasc Health Risk Manag 2020;16:467-78. [PMID: 33262599 DOI: 10.2147/VHRM.S276530] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
86 Samad N, Sodunke TE, Banna HA, Sapkota A, Fatema AN, Iskandar K, Jahan D, Hardcastle TC, Nusrat T, Chowdhury TS, Haque M. Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic. Risk Manag Healthc Policy 2020;13:2707-28. [PMID: 33262668 DOI: 10.2147/RMHP.S281388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
87 Qin W, Dong F, Zhang Z, Hu B, Chen S, Zhu Z, Li F, Wang X, Zhang Y, Wang Y, Zhen K, Wang J, Elalamy I, Li C, Zhai Z, Davidson BL, Wang C. Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era. Thromb Res 2021;198:19-22. [PMID: 33249247 DOI: 10.1016/j.thromres.2020.11.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 Stratton CW, Tang YW, Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol 2021;93:1320-42. [PMID: 33073355 DOI: 10.1002/jmv.26610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
89 Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gómez-Arbeláez D, Ibarra G, Garcia-Gutierrez A. [Mortality of covid-19 patients with vascular thrombotic complications]. Med Clin (Barc) 2021;156:112-7. [PMID: 33342556 DOI: 10.1016/j.medcli.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
90 Kardeş S, Kuzu AS, Raiker R, Pakhchanian H, Karagülle M. Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends. Rheumatol Int 2021;41:329-34. [PMID: 33070255 DOI: 10.1007/s00296-020-04728-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
91 Mélo Silva Júnior ML, Souza LMA, Dutra REMC, Valente RGM, Melo TS. Review on therapeutic targets for COVID-19: insights from cytokine storm. Postgrad Med J 2021;97:391-8. [PMID: 33008960 DOI: 10.1136/postgradmedj-2020-138791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
92 Narayan P, Angelini GD. Vascular emergencies-The new COVID-19 crisis? J Card Surg 2021;36:2913-5. [PMID: 33000468 DOI: 10.1111/jocs.15072] [Reference Citation Analysis]
93 Medetalibeyoglu A, Emet S, Kose M, Akpinar TS, Senkal N, Catma Y, Kaytaz AM, Genc S, Omer B, Tukek T. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study. Angiology 2021;72:187-93. [PMID: 32969233 DOI: 10.1177/0003319720961267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
94 Misra DP, Gasparyan AY, Zimba O. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int 2020;40:1741-51. [PMID: 32880032 DOI: 10.1007/s00296-020-04694-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
95 Melenotte C, Silvin A, Goubet AG, Lahmar I, Dubuisson A, Zumla A, Raoult D, Merad M, Gachot B, Hénon C, Solary E, Fontenay M, André F, Maeurer M, Ippolito G, Piacentini M, Wang FS, Ginhoux F, Marabelle A, Kroemer G, Derosa L, Zitvogel L. Immune responses during COVID-19 infection. Oncoimmunology 2020;9:1807836. [PMID: 32939324 DOI: 10.1080/2162402X.2020.1807836] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]